Dr. Ranon E Mann , MD
Dermatology • Bronx, NY
111 East 210th Street, Division Of Dermatology
Bronx, NY 104671246
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 13, 2006; this date does not establish years in practice.
-
Published CMS data list 833 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 250 service units.
- 99213 — Established patient outpatient office visit: 161 service units.
- 17003 — Destruction of precancer skin growth, 2-14 growths: 95 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 14 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,092 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole — 476 prescription fills, including refills.
- Hydrocortisone — 299 prescription fills, including refills.
- Triamcinolone Acetonide — 210 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 51 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Dermatology in Bronx, NY (2024, 23 clinicians with data). Median for this group: 289. Middle half: 54 to 912.
Fewer Medicare Part B services than 60% of clinicians listed under Dermatology in New York (2024, 762 clinicians with data). Median for this group: 1,320. Middle half: 472 to 2,886.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,059 in 2020 to 833 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
111 East 210th Street
Division Of Dermatology
Bronx, NY 104671246
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Montefiore Medical Center. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Albert Einstein College Of Medicine Of Yeshiva University
1995
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
378 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $72,244 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $53,327 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,596 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,855,843 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $27.98 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
Years since graduation
31 years (graduated 1995)
CMS Doctors and Clinicians data list 1995 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Mann has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Mann as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Bronx and New York
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Dermatology in Bronx, NY (2024, 23 clinicians with data). Median for this group: 289. Middle half: 54 to 912.
Fewer Medicare Part B services than 60% of clinicians listed under Dermatology in New York (2024, 762 clinicians with data). Median for this group: 1,320. Middle half: 472 to 2,886.
Medicare-allowed amount
A higher Medicare-allowed amount than 65% of clinicians listed under Dermatology in Bronx, NY (2024, 23 clinicians with data). Median for this group: $27,299. Middle half: $5,163 to $81,796.
Close to the middle for clinicians listed under Dermatology in New York (2024, 762 clinicians with data). Median for this group: $98,852. Middle half: $39,890 to $226,158.
Paid by Medicare
A higher Medicare payment amount than 65% of clinicians listed under Dermatology in Bronx, NY (2024, 23 clinicians with data). Median for this group: $21,253. Middle half: $4,012 to $59,007.
Close to the middle for clinicians listed under Dermatology in New York (2024, 762 clinicians with data). Median for this group: $71,311. Middle half: $28,165 to $165,657.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Dermatology in Bronx, NY (2024, 26 clinicians with data). Median for this group: 757. Middle half: 237 to 1,412.
More Part D prescriptions than 95% of clinicians listed under Dermatology in New York (2024, 903 clinicians with data). Median for this group: 433. Middle half: 149 to 933.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Bronx, NY (2024, 26 clinicians with data). Median for this group: $237,448. Middle half: $31,167 to $503,462.
A higher Part D drug cost than 95% of clinicians listed under Dermatology in New York (2024, 903 clinicians with data). Median for this group: $39,803. Middle half: $4,838 to $194,684.
37 active clinicians are listed under Dermatology with a practice address in Bronx, NY (1,218 in New York).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bronx
18.9% of these 37 clinicians have the CMS telehealth indicator.
45.9% of these 37 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 21% from 1,059 in 2020 to 833 in 2024.
- 2020: 1,059
- 2021: 1,013
- 2022: 764
- 2023: 778
- 2024: 833
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $70,036 in 2020 and $72,244 in 2024.
- 2020: $70,036
- 2021: $79,354
- 2022: $67,482
- 2023: $70,535
- 2024: $72,244
-
Paid by Medicare
Paid by Medicare stayed about the same: $49,842 in 2020 and $53,327 in 2024.
- 2020: $49,842
- 2021: $58,512
- 2022: $50,063
- 2023: $50,577
- 2024: $53,327
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 14% from 2,708 in 2020 to 3,092 in 2024.
- 2020: 2,708
- 2021: 2,279
- 2022: 2,267
- 2023: 2,484
- 2024: 3,092
-
30-day fills
30-day fills increased 22% from 2,942 in 2020 to 3,596 in 2024.
- 2020: 2,942
- 2021: 2,527
- 2022: 2,580
- 2023: 2,902
- 2024: 3,596
-
Part D drug cost
Part D drug cost increased 134% from $1,220,332 in 2020 to $2,855,843 in 2024.
- 2020: $1,220,332
- 2021: $1,375,938
- 2022: $2,054,749
- 2023: $2,587,145
- 2024: $2,855,843
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $194.98 in 2023 to $27.98 in 2025.
- 2023: $194.98
- 2024: $99.99
- 2025: $27.98
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $27.98.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $27.98 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
250 | 169 | $520.00 | $109.99 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
161 | 127 | $400.00 | $77.71 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
95 | 28 | $90.00 | $8.16 |
|
17000
Destruction of precancer skin growth, 1 growth
|
67 | 48 | $480.00 | $74.26 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
51 | 39 | $505.00 | $115.06 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
41 | 36 | $730.00 | $147.98 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
31 | 24 | $435.00 | $68.96 |
|
11102
Biopsy of related skin growth, first growth
|
30 | 30 | $640.00 | $120.56 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
25 | 16 | $93.80 | $18.56 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
22 | 22 | $518.18 | $98.15 |
|
17110
Destruction of skin growth, 1-14 growths
|
21 | 18 | $673.81 | $140.78 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
15 | 15 | $770.00 | $135.28 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
13 | 12 | $95.00 | $19.47 |
|
17110
Destruction of skin growth, 1-14 growths
|
11 | 11 | $615.00 | $84.78 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 476 | 14,123 | $19,611.83 | 135 |
| Hydrocortisone | Hydrocortisone | 299 | 7,589 | $4,043.51 | 141 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 210 | 5,941 | $2,337.51 | 90 |
| Halobetasol Propionate | Halobetasol Propionate | 162 | 5,122 | $10,288.91 | 80 |
| Ammonium Lactate | Ammonium Lactate | 146 | 4,704 | $3,207.03 | 53 |
| Fluocinonide | Fluocinonide | 107 | 3,483 | $5,602.25 | 38 |
| Mupirocin | Mupirocin | 107 | 2,215 | $730.07 | 55 |
| Ciclopirox | Ciclopirox Olamine | 87 | 2,563 | $1,991.91 | 35 |
| Mometasone Furoate | Mometasone Furoate | 83 | 2,291 | $1,707.43 | 33 |
| Clobetasol Propionate | Clobetasol Propionate | 81 | 2,296 | $4,898.20 | 49 |
| Clindamycin Phosphate | Clindamycin Phosphate | 76 | 2,287 | $3,814.60 | 32 |
| Betamethasone Valerate | Betamethasone Valerate | 74 | 1,970 | $1,899.75 | 34 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 68 | 2,239 | $2,354.48 | 30 |
| Metronidazole | Metronidazole | 63 | 1,985 | $2,544.04 | 27 |
| Minoxidil | Minoxidil | 63 | 4,395 | $396.86 | 23 |
| Tacrolimus | Tacrolimus | 57 | 1,923 | $11,304.33 | 27 |
| Dupixent Pen | Dupilumab | 54 | 1,470 | $218,913.09 | 12 |
| Opzelura | Ruxolitinib Phosphate | 53 | 1,620 | $103,625.63 | 16 |
| Fluocinolone Acetonide | Fluocinolone/Shower Cap | 44 | 1,299 | $1,630.63 | 16 |
| Otezla | Apremilast | 44 | 1,438 | $222,899.80 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 890 | $432.28 | 27 |
| Methotrexate | Methotrexate Sodium | 38 | 1,476 | $753.83 | — |
| Skyrizi Pen | Risankizumab-Rzaa | 38 | 2,912 | $747,150.18 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | 1,230 | $217.94 | 13 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 36 | 1,055 | $1,824.74 | 20 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20050311000173
NY
8628022621
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Montefiore Medical Center
111 E 210th St, Bronx, NY 104672401
Montefiore Medical Center
3400 Bainbridge Ave, Bronx, NY 104672404
Phone: 9143786148
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner
Career & Practice History
NPI enumerated October 13, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Dermatology Specialists in Bronx
- Dr. Caroline Halverstam, MD
- Dr. Renee Fruchter, MD
- Dr. Kenneth Bloom, MD
- Ashley Jacobs
- Dr. Elena Pollack, MD
- Dr. Paul Dantzig, MD
Mailing Address
111 East 210th Street, Division Of Dermatology
Bronx, NY 104671246
Phone: 7189202680